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Pediatric patients with diabetic ketoacidosis (DKA) are a unique subset of patients who 
arrive to the emergency department (ED) for care, and differ from adults regarding 
symptomology, treatment, and adverse effects. Nurses who will encounter this patient 
population must have adequate knowledge and confidence to care for them, yet research 
continues to show a gap in practice. The purpose of this doctoral project was to determine 
if a staff education project would increase ED nurse knowledge and confidence in caring 
for pediatric emergency patients with DKA. Utilizing Kirkpatrick’s evaluation model, an 
evidence-based staff education program was formulated, reviewed by an expert panel, 
administered via a self-learning packet, and completed by 35 ED nurses. Sources of 
evidence used to develop the education program were from the International Society for 
Pediatric and Adolescent Diabetes, the American Diabetes Association, and the 
Emergency Nurses Association and the Society of Critical Care Medicine. Evaluation of 
learning outcomes was completed using a paired-samples t-test. Findings from this 
project demonstrated that a self-learning module on pediatric DKA was successful in 
improving both knowledge (p < .001) and confidence levels (p < .001) of ED registered 
nurses with 100% recommending the course to peers. Recommendations are to provide 
additional staff education in clinical management of pediatric patients with high risk and 
low volume diagnoses. The staff education project contributed to positive social change 
by improving nurse knowledge, which may improve patient care and reduce adverse 
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Section 1: Nature of the Project 
Introduction 
The emergency department (ED) nurse treats an array of patients with multiple 
chief complaints, comorbidities, and complexities in care. Pediatric patients are a 
specialized group that frequent the ED and have a risk of being assessed inappropriately. 
This is especially true for pediatric patients with diabetic ketoacidosis (DKA) as most 
patients with diabetes are adults, and children differ from adults in the areas of 
epidemiology, pathophysiology, response to therapy, and with developmental 
considerations (Chiang et al., 2018). Since 2000, there has continued to be a rise in the 
number of pediatric patients diagnosed with diabetes (Centers for Disease Control and 
Prevention, 2018). For the pediatric patients who are newly diagnosed with diabetes, 
approximately 25%-30% present to the ED with an initial diagnosis of DKA and begin 
initial treatment at that time (Dabelea et al., 2014; Long & Koyfman, 2017; von 
Oettingen, Rhodes, & Wolfsdorf, 2018).  
There is an increased risk in younger patients, those with lower incomes, and 
those who lack health insurance to present with DKA prior to a diabetes diagnosis 
(Dabela et al., 2014; Long & Koyfman, 2017; von Oettingen et al., 2018). In addition, 
these patients may present to community EDs where educational resources for staff may 
be limited (Zee-Cheng, Webber, & Abu-Sultaneh, 2017). A sustained presence of 
alertness of healthcare providers to signs and symptoms of diabetic complications is 
required, especially in patients with no prior diagnosis of diabetes (Dabela et al., 2014). 
There is a practice gap regarding the management of pediatric DKA despite 
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internationally recognized guidelines for treatment (Clark & Dalabih, 2014; Zee-Cheng et 
al., 2017). The International Society for Pediatric and Adolescent Diabetes (ISPAD) 2018 
clinical practice guidelines recommend that healthcare providers who have the potential 
to care for pediatric DKA patients complete training in the assessment and management 
of the disease process in diabetes (Wolfsdorf et al., 2018). My Doctor of Nursing Practice 
(DNP) project utilized the DNP Staff Education Manual to develop training that would 
improve staff understanding of the complexities of pediatric DKA and increase comfort 
in the assessment and management of these patients. My project facilitated social change 
at the project site by improving emergency nurse knowledge of evidence-based 
guidelines for the emergent care and management of children with diabetes.  
Problem Statement 
The project site was a nonprofit urban county ED in the Western region of the 
United States. There had been a recurrent request from the registered nurses (RNs) in the 
project site ED for supplementary education on the treatment and care of pediatric 
patients with DKA. The leadership team recognized the demand for more education for 
ED RNs on evidence-based management of pediatric patients who present in DKA. Lack 
of knowledge or complete understanding of the pathophysiology, symptomology, and 
treatment of pediatric DKA could lead to delays in identification, delays in care, and poor 
patient outcomes and complications (Brink, 2014). In addition, missed or late diagnosis, 
delayed or inappropriate treatment, and inappropriate monitoring can be associated with 
increased morbidity and mortality and increased costs to hospitals (Brink, 2014). This 
doctoral project addressed the need for formal education for ED nurses related to the 
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management of pediatric DKA. It was necessary to improve staff knowledge of the 
pathophysiology, symptomology, and treatment for this patient population in order for 
the ED RNs to effectively advocate for their patients and ensure the highest quality of 
care to be provided. This doctoral project holds significance for the field of nursing 
practice in that it promotes the education of frontline nursing staff in the identification 
and care of a specialized patient population. 
Purpose 
Pediatric patients who present to the ED in DKA require timely and evidence-
based care (Chiang et al., 2018; Wolfsdorf, et al., 2018). The gap in practice that was 
addressed in this DNP staff education project was the need for staff nurse education to 
improve knowledge and confidence in caring for pediatric patients in DKA. The practice-
focused question for this project was:  
PFQ: For RNs working in a county ED, did a staff education program on 
evidence-based treatment for pediatric patients who present with DKA improve 
knowledge and confidence of the pathophysiology and treatment of DKA in 
pediatric patients?   
This education assisted in closing the gap by increasing the knowledge base of the ED 
RN caring for this patient population. 
Nature of Doctoral Project 
I completed a literature review of peer-reviewed articles using Medline, CINAHL, 
Cochrane Review, and PubMed databases to identify evidence-based practice 
recommendations for emergency nurses who are treating pediatric patients with diabetes. 
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The search was limited to publications from the past 5 years and included the following 
combination of key words: emergency, emergency department, pediatric, diabetic 
ketoacidosis, clinical practice guideline, and evidence. Primary sources of evidence 
included expert opinion, current clinical practice guidelines, and position statements from 
relevant professional organizations including, but not limited to, the Emergency Nurses 
Association, Society of Pediatric Nurses, American Academy of Pediatrics, American 
Colleges of Emergency Physicians, and the American Diabetes Association. Examples 
included the Emergency Nurse Core Curriculum and the ISPAD 2018 clinical practice 
guidelines. Material from the Society of Critical Care Medicine’s Pediatric Fundamental 
Critical Care Support textbook was also utilized.   
This staff education project was delivered via a self-learning module (see 
Appendix A) with a pre- and posttest (see Appendix B). The gap-in-practice that was 
addressed was the nurse’s knowledge and level of comfort in regard to the assessment 
and care of the pediatric DKA patient. 
This project included education on the assessment, pathophysiology, and 
treatment of pediatric DKA. The education included 
• the pathophysiology of pediatric DKA, 
• the initial and delayed signs and symptoms of DKA in the pediatric patient, 
• treatment of DKA specific to the pediatric population, 
• potential complications of pediatric DKA and treatment of pediatric DKA, 
and  
• signs of resolution of pediatric DKA. 
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The primary source of evidence for this project came from the results of the pre- and 
posttest. A pretest was created based on the topics listed above from the sources of 
evidence listed above. The pretest was vetted through the project team, as was the 
education. This pretest was completed prior to the educational program to assess baseline 
knowledge. Immediately following the education program, the test was taken again to 
evaluate learning outcomes from the course. Participants assigned themselves a number 
to write on their pre- and posttest, which allowed comparison of scores. A paired t test 
was completed to compare pre- and posttest scores to determine whether the educational 
program was effective. Findings from the before and after education scores answered the 
project question related to whether education on the management of pediatric patients 
with DKA improved knowledge and understanding of the pathophysiology and treatment 
of DKA in pediatric patients. 
Significance 
Members of the project team included the clinical educator of the ED, an ED 
physician specialized in pediatric care, a pediatric intensive care unit (PICU) physician, 
and a clinical educator from the PICU. Stakeholders included ED RNs, pediatric 
emergency patients with DKA, and patients’ families. The significance of this project 
was that a successful implementation of an educational program for the ED RNs 
regarding pediatric DKA may lead to earlier identification, appropriate care, and increase 
in quality of care for the pediatric patient. Proper understanding of the pathophysiology 
of DKA allows for healthcare providers to provide the best treatment for patients who 
arrive in DKA (Brink, 2014). This care will then continue to be provided upon admission, 
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potentially limiting any complications from this disease process and decreasing length of 
stay due to appropriate and rapid treatment of DKA in the pediatric patient. 
This doctoral project holds significance for the nursing field because the 
education can be applied in other EDs, especially those EDs that have a low pediatric 
patient volume or have newly graduated RNs who may be unfamiliar with pediatric 
DKA. This education could also be adapted for different settings such as pediatric 
medical offices, inpatient pediatric departments, and county education. Staff education 
related to pediatric DKA may result in positive social change by improving the care of 
patients with pediatric DKA and reducing adverse outcomes.  
Summary 
As the pediatric population diagnosed with diabetes continues to rise with a 
significant percentage first presenting with DKA, clinicians who are knowledgeable in 
the symptomology and treatment of DKA can advocate for appropriate treatment prior to 
serious complications occurring, which would result in improved patient outcomes 
(Brink, 2014; Dabela et al., 2014). Education that increases ED RNs clinical knowledge 
in the care of pediatric DKA patients has a positive impact on social change by 
improving outcomes for this patient population. In addition, the success of this education 
could be utilized as a guide for future education on other high-risk patient education 
topics. The hope was that this education allowed for better outcomes for pediatric 
patients, including potential decreased need for hospitalization and decreased length of 
stay. By applying the strategy of education for ED RNs to promote the health of the 
community pediatric diabetic population, this project supported the mission of Walden 
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University to promote positive social change. In the next section I discuss the theoretical 




Section 2: Background and Context 
Introduction 
As stated in the above section, there has been a rise in the diabetic pediatric 
population with a large percentage of these patients initially being identified with DKA 
when being treated in the ED. The practice-focused question for this doctoral project was:  
PFQ: For RNs working in a county ED, did a staff education program on 
evidence-based treatment for pediatric patients who present with DKA improve 
knowledge and confidence of the pathophysiology and treatment of DKA in 
pediatric patients?   
The purpose of this project was to aid in closing the gap between ED RN knowledge and 
the appropriate care of a pediatric DKA patient. In this section, I discuss concepts and 
models used for this project, relevance to nursing practice, local background, the role of 
the DNP student, and the role of the project team. 
Concepts, Models, and Theories 
Kirkpatrick Evaluation Model 
The model used for the evaluation of this training course was the Kirkpatrick 
evaluation model. This model has four levels of evaluation: reaction, learning, behavior, 
and results, and the updated model applies more emphasis on behavior and results than 
the previous model (Kirkpatrick & Kirkpatrick, 2016). The first level, reaction, is defined 
as the extent to which the learners deem the education to be constructive, engaging, and 
pertinent to them (Kirkpatrick & Kirkpatrick, 2016). The course included a postcourse 
survey that included questions on how satisfying, engaging, and relevant the education 
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was to aid in the evaluation of the level of reaction. The second level is learning, or the 
extent to which learners acquire the intended comprehension, proficiencies, attitudes, 
assurance, and commitment based on their participation in the training (Kirkpatrick & 
Kirkpatrick, 2016). For this project, this was evaluated by reviewing the posttest results 
to determine that there had been a change in the knowledge level of the ED RNs.  
Behavior, the third stage, is defined as the extent to which the education is applied 
to the work setting (Kirkpatrick & Kirkpatrick, 2016). Kirkpatrick & Kirkpatrick (2016) 
discussed that a key concept in this stage is on-the-job learning, which creates the 
expectation that employees are responsible for their learning and performance. As this 
course was voluntary, the staff were empowered to complete the course because of their 
desire to learn and improve their knowledge and skills. Behavior is broken down into 
critical behaviors and required drivers; specific actions that lead to the desired results and 
processes that promote critical behaviors (Kirkpatrick & Kirkpatrick, 2016). In this 
intervention, the required driver was the education provided to the learners in addition to 
references available to the learner; critical behaviors would be determined via 
engagement and understanding of the education in addition to the use of the knowledge 
gained when working with pediatric patients.  
The last stage is results, the extent to which measurable outcomes occur due to the 
education provided (Kirkpatrick & Kirkpatrick, 2016). The updated model states that for 
nonprofit organizations, this can also be described as accomplishing goals while using 
resources responsibly (Kirkpatrick & Kirkpatrick, 2016). This result, although not being 
measured for this project, would be that providing the most evidence-based, highest level 
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of quality care to pediatric DKA patients would be a successful outcome. Average 
admission rates and length of stay decreases, along with fewer ICU admissions, would 
show that the project was a success. 
Clarification of Terms 
Emergency department nurse: Any registered nurse currently working in the 
emergency department that was the setting of this project. 
Learner/staff/nurse: The participant and receiver of the project education. This 
was any ED RN who completed the course. 
Relevance to Nursing Practice 
The epidemiology, pathophysiology, and response to treatment for diabetes 
differs in the pediatric patient population with the added consideration of developmental 
stages (Chiang et al., 2018). Approximately 20%-30% of newly diagnosed diabetic 
pediatric patients have this disease process diagnosed after they present to the ED with a 
diagnosis of DKA (Dabelea et al., 2014; Long & Koyfman, 2017; von Oettingen et al., 
2018). Additionally, pediatric diabetes patients are increasing in population with each 
passing year (Centers for Disease Control and Prevention, 2018). When reviewing this 
data concurrently, the conclusion can be made that there will be an annual increase in 
pediatric DKA patients presenting to the ED, without a prior history of diabetes. 
Thorough knowledge of the pathophysiology, assessment, and treatment of this patient 
population is required to provide the most evidence-based and high-quality care. If 
knowledge and confidence by ED RNs are lacking, delays in identification and care can 
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lead to complications and poor patient outcomes including increased morbidity and 
mortality with increased length of stay and costs (Brink, 2014).  
The current evidence includes internationally recognized guidelines for the 
treatment of pediatric DKA; however, there continues to be a practice gap (Clark & 
Dalabih, 2014; Zee-Cheng et al., 2017). The 2018 clinical practice guidelines published 
by the ISPAD recommend that healthcare providers who have the potential to care for 
pediatric DKA patients have education on the management of this patient population 
(Wolfsdorf et al., 2018). 
Lack of following established protocols contribute to preventable DKA morbidity 
and mortality (Brink, 2014). Mortality rates from pediatric DKA have not changed since 
the 1970s (Brink, 2014); there are continued concerns that these rates will not change in 
the future either (Clark & Dalabih, 2014). DKA continues to be the leading cause of 
death for children aged 15 years of age or less with diagnosed diabetes mellitus type 1 
(Wolfdorf et al., 2018). DKA complications can occur due to errors in initial or 
subsequent orders and a lack of appropriate monitoring to the dynamic patient changes 
that can occur with this disease process and its treatment (Brink, 2014). Despite 
established guidelines for treatment of pediatric DKA, there continues to be a practice 
gap that occurs at all organizations, not just rural or nonpediatric organizations (Zee-
Cheng et al., 2017). Furthermore, even in organizations with standardized order sets, 
compliance to the order sets can be subpar, leading to suboptimal care of these critical 
patients (Clark & Dalabih, 2014; Koves et al., 2014; Ronsley, Islam, Ronsley, Metzger, 
& Panagiotopoulos, 2018). The use of standardized order sets with a systematic review of 
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literature and dissemination of education to the staff can lead to decreased incidents of 
adverse effects and a decreased length of stay (Koves et al., 2014). Teaching health care 
professionals to understand the pathophysiology of DKA helps them provide better 
patient education and better treatment when DKA occurs (Brink, 2014). Additionally, 
appropriately trained healthcare professionals may aid in improving patient outcomes and 
decreasing length of stay (American Diabetes Association, 2019). 
This doctoral project addressed the need for formal education for ED nurses 
related to the management of pediatric DKA. It was necessary to improve staff 
knowledge of the pathophysiology, symptomology, and treatment for this patient 
population to enable ED RNs to effectively advocate for their patients and ensure the 
highest quality of care to be provided.  
This doctoral project advanced nursing practice by promoting the education of 
frontline nursing staff in the care and management of the specialized patient population 
of pediatric patients with DKA. Current evidence suggested that this patient population 
requires judicious evidence-based care (Chiang et al., 2018; Wolfsdorf, et al., 2018); at 
this organization, there was a gap in this practice. This gap was addressed in this DNP 
staff education project by providing education to ED RNs to improve their 
comprehension and confidence in caring for pediatric DKA patients. The goal of this 
DNP project was to contribute to the closing of this gap by increasing the number of ED 
RNs who had adequate knowledge in the care for this patient population. 
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Local Background and Context 
The institution in which this project took place was an urban, county nonprofit ED 
in the Western region of the United States that sees an average daily census of 300-325 
patients a day. This institution sees a moderate number of pediatric patients, with the 
organization providing primary care for those without private insurance or without 
insurance at all. ED staff had discussed concerns regarding comfort level assessing and 
treating pediatric DKA patients in addition to monitoring for complications; in discussion 
with the leadership team, this practice focused question was consequently developed. 
Mission Statement and Nursing Values 
This DNP project aligned with the organization’s mission statement to provide 
high-quality health care services and to improve the health of the community. Core 
nursing values that this project aligned with included patient-centered care and excellence 
as I hoped this project would lead to improved care of pediatric patients in addition to 
educating nurses in evidence-based care. 
State Context 
As stated in the previous chapter, approximately 20%-30% of pediatric patients 
newly diagnosed with diabetes present to the ED with an initial diagnosis of DKA; in 
addition to there being an increased risk with younger patients, the risks are also greater 
for lower socioeconomic status groups and those with a lack of health insurance (Dabela 
et al., 2014; Long & Koyfman, 2017; von Oettingen et al., 2018). For the county in which 
this hospital provides care, about 15% of the population had no health insurance, with 
half of these being children; for those with insurance, less than half had employer-based 
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health care while others had direct-purchase health insurance, Medicare, or Medicaid 
(U.S. Census Bureau, 2017). Data on the number of pediatric patients with diabetes were 
not available. 
Role of the Doctor of Nursing Practice Student 
My role in the doctoral project was all-encompassing regarding planning, 
implementing, and evaluating the program. I completed all research concerning the 
current evidence and the organization-specific guidelines, and contacted the project team 
for feedback and approval of the course and course material prior to the start of the 
intervention. Planning included the formation of the education curriculum and the pre- 
and posttest assessments. I completed a thorough literature review and analysis in 
addition to a review of current clinical practice guidelines, position statements, and 
material from textbooks, and I created a robust PowerPoint educational course. The 
project objectives included: 
1. developing and implementing an educational course using PowerPoint to 
educate on pediatric DKA, 
2. educating ED RNs on the pathophysiology and treatment of DKA in pediatric 
patients, and 
3. evaluating the effectiveness of the educational course upon review of the pre- 
and posttest scores. 
One of my motivations for this doctoral project was that as a clinician I have 
always taken it upon myself to stay up to date on evidence-based practice to provide the 
best care for my patients. As a clinical educator, this practice evolved into wanting to 
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teach others so that they could also provide the best care for their patients. The majority 
of ED RNs, especially those who do not work in a pediatric ED, can be unfamiliar and 
uncomfortable with the care of the pediatric patient population; too often they are 
assessed and treated as adults; however, this is not appropriate per evidence-based 
guidelines. Providing this education to the ED RNs could aid in increasing the ED RNs’ 
skill and comfort in assessing and caring for pediatric patients. A potential bias that I may 
have had for this project was that as the sole researcher and developer of the education 
project, I may have been unable to see any gaps in the education or weaknesses in the 
course and course material. Steps that I took to prevent this was to utilize a project team 
that provided feedback and signed off on the course and course materials prior to the start 
of the course. 
Role of the Project Team 
The project team consisted of the ED clinical educator, a pediatric emergency 
medicine provider, the PICU clinical educator, and a PICU physician. The members of 
the team reviewed the educational content and materials and approved them while I 
assumed all responsibilities as the leader of the project team. All material was shared 
with the team via e-mail, and I requested feedback within 1-2 weeks with reminders sent 
out after the first week. The ED and PICU medical team taught a separate pediatric 
course, and one of the approved textbooks was recommended and used for this project. 
Summary 
In summary, this doctoral project was designed to educate ED RNs on the 
pathophysiology and treatment of DKA in the pediatric patient population. The project 
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was reviewed utilizing the Kirkpatrick evaluation model. I have presented relevance to 
nursing practice, local context, and relevant background. I have also discussed the role of 
the doctoral student and the project. In the next section, I discuss the practice problem, 
sources of evidence, and analysis methods. 
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Section 3: Collection and Analysis of Evidence 
Introduction 
At a nonprofit urban county ED, there had been recurrent requests from the staff 
and leadership for additional education regarding the treatment of pediatric patients with 
DKA. Delays in the identification and care along with poor patient outcomes and 
complications can be caused by a deficit in knowledge of the pathophysiology, 
symptomology, and treatment of pediatric DKA. This can lead to increased morbidity, 
increased mortality, and increased costs to hospitals (Brink, 2014). The purpose of this 
doctoral project was to educate ED RNs on the identification and treatment of pediatric 
DKA. In the previous section, I discussed the extent of the problem at the project site by 
describing the background and context as well as the roles of those involved in the 
project. In this section, I discuss the practice-focused question and design for compilation 
and analysis of data.  
Practice-Focused Question 
The gap in practice at the location of this project was the need for improvement in 
staff nurse knowledge and confidence in caring for pediatric patients with DKA. The 
practice-focused question for this doctoral project was:  
PFQ: For RNs working in a county ED, did a staff education program on 
evidence-based treatment for pediatric patients who present with DKA improve 
knowledge and confidence of the pathophysiology and treatment of DKA in 
pediatric patients?   
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The purpose of the project, educating ED RNs on pediatric DKA, aligned with the 
practice-focused question as the education was provided to the staff and then the staff 
were assessed for knowledge and confidence gained with a pre- and posttest, in addition 
to a course evaluation. 
Sources of Evidence 
The sources of evidence included clinical practice guidelines from the ISPAD, a 
consensus statement and standards of care from the American Diabetes Association, and 
textbooks created by and endorsed by the Emergency Nurses Association and the Society 
of Critical Care Medicine. To answer the practice-focused question, I used research 
evidence to educate the nurses and to formulate the pre- and posttest questions and 
answers (see Appendix C), in addition to a course evaluation that was used by the 
organization. The collection and analysis of this information allowed for the course 
material to be evidence-based and from vetted and reliable sources to provide a 
comprehensive education for the nurses. The collection of the pre- and posttest allowed 
for analysis of knowledge and confidence gained from the course regarding the care of a 
pediatric patient with DKA. The staff education program plan was be based on evidence 
from the literature as outlined below.  
Assessment and Monitoring 
The assessment of pediatric DKA includes assessment of dehydration via 
capillary refill, abnormal skin turgor, dry mucous membranes, sunken eyes, absent tears, 
weak pulses, and cool extremities; severe dehydration may be associated with weak or 
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absent peripheral pulses, hypotension, and oliguria (Wolfsdorf et al., 2018; Wolfsdorf, 
Glaser, & Sperling, 2006;).  
Clinical signs of DKA include polydipsia, polyuria, nocturia, enuresis, 
dehydration, tachypnea, Kussmaul respirations, nausea, vomiting, abdominal pain, 
confusion, drowsiness, decreasing level of consciousness, and loss of consciousness 
(Bruzzini et al., 2013; Logee, 2020; Wolfsdorf et al., 2018). Level of consciousness is 
assessed via the Glasgow Coma Scale, and if the patient does not have normal airway 
protective reflexes, the airway should be secured and a nasogastric tube placed to prevent 
aspiration (Brink, 2014; Wolfsdorf et al., 2018; Wolfsdorf et al., 2006). Cardiac 
monitoring should be initiated to monitor cardiac rhythm, specifically assessing T-waves 
for signs of hyper- or hypokalemia (Wolfsdorf et al., 2018). Additionally, accurately 
measured weight is vital, as all treatment is weight-based; a stated or historical weight is 
not appropriate (Wolfsdorf et al., 2006). During treatment, at least hourly vital signs, 
blood glucose, intake and output, and neurological status should be assessed, along with 
electrolytes every 2 hours (Wolfsdorf et al., 2018). 
Orders and Diagnostics 
Orders to anticipate include serum glucose, electrolytes, blood urea nitrogen, 
creatinine, serum osmolality, venous pH and pCO2, a complete blood count, urinalysis, 
and appropriate cultures if the patient is febrile (Wolfsdorf et al., 2018; Wolfsdorf et al., 
2006;). Hourly, or more frequently if indicated, assessment and monitoring should 
include vital signs, neurologic status, administered insulin, fluid intake and output, and 
capillary blood glucose testing (Wolfsdorf et al., 2006). Laboratory testing, including 
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serum electrolytes, glucose, calcium, magnesium, phosphorous, and blood gases should 
be repeated every 2-4 hours or more frequently if clinically indicated (Wolfsdorf et al., 
2006) 
DKA is diagnosed when there is a presence of hyperglycemia (blood glucose 
more than 200 mg/dl), a venous pH of less than 7.3 or a serum bicarbonate level less than 
15 mmol/L, and with the presence of ketonemia or moderate to large ketonuria (Logee, 
2020; Wolfsdorf et al., 2018). Although DKA is characterized by depletion of water and 
electrolytes both from intra- and extracellular fluid compartments, most pediatric patients 
will present with normal or even high blood pressures just as urine output will be present 
until renal blood flow decreases to a critical level (Wolfsdorf et al., 2018). An anion gap 
is normally 10-14 mmol/L; however, in DKA it is more likely to be 20-30 mmol/L or 
higher if accompanied by lactic acidosis (Wolfsdorf et al., 2018). The formula is Na - (Cl 
+ HCO3) for calculating an anion gap (Wolfsdorf et al., 2006; Wolfsdorf et al., 2018). 
The severity of DKA is defined by the degree of acidosis in the venous pH: a pH of 7.2-
7.3 is mild, 7.1-7.2 is moderate, and a pH < 7.1 is severe DKA (Wolfsdorf et al., 2006). 
Pathophysiology of Pediatric Diabetic Ketoacidosis 
Pediatric DKA occurs when there is a deficiency in the circulating insulin along 
with increased levels of the following counterregulatory hormones: catecholamine, 
glucagon, cortisol, and growth hormone (Chiang et al., 2018; Wolfsdorf et al., 2018; 
Wolfsdorf et al., 2006). This combination causes an accelerated catabolic state evidenced 
by an increase in glucose formation via the liver and kidneys and impairs peripheral 
glucose utilization, both leading to hyperglycemia and hyperosmolality (Wolfsdorf et al., 
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2006; Wolfsdorf et al., 2018). The combination also causes lipolysis and ketogenesis, in 
turn causing the ketonemia and ketonuria and metabolic acidosis (Wolfsdorf et al., 2018; 
Wolfsdorf et al., 2006). The hyperglycemia and hyperketonemia lead to osmotic diuresis, 
dehydration, and loss of electrolytes that are also exacerbated with vomiting that can 
occur with severe ketosis (Wolfsdorf et al., 2018; Wolfsdorf et al., 2006;). The cycle then 
increases as stress hormone is further produced, leading to more severe insulin resistance, 
worsening hyperglycemia and hyperketonemia, lactic acidosis from hypoperfusion, 
potential sepsis, and finally fatal dehydration and metabolic acidosis (Wolfsdorf et al., 
2018). 
Treatment of Pediatric Diabetic Ketoacidosis 
As with every patient, the treatment is individualized; some patients may have 
mild dehydration while others present with severe dehydration (Wolfsdorf et al., 2018). 
Goals of treatment include to correct the acidosis and reverse ketosis, correct 
dehydration, normalize blood glucose levels, monitor for complications, and identify and 
treat precipitating events (American Diabetes Association, 2019; Wolfsdorf et al., 2018). 
Emergent treatment should follow the guidelines of Pediatric Advanced Life Support and 
include immediate diagnostic testing, including blood work and urine, assessment of 
dehydration and level of consciousness, and the insertion of two intravenous (IV) access 
points (Wolfsdorf et al., 2018). Central venous access should be avoided due to an 
increased risk of thrombosis (Wolfsdorf et al., 2018). 
Fluid replacement is advised to occur prior to the start of insulin therapy to 
expand the blood volume and restore peripheral circulation with the goal to restore fluid 
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deficit over 24-48 hours (Wolfsdorf et al., 2018; Wolfsdorf et al., 2006). Fluid 
replacement should start with isotonic fluid at a rate of 10ml/kg over 30-60 minutes, or 
more rapidly if poor tissue perfusion is present, and this may be repeated based on the 
calculated fluid replacement requirements (Bruzzini et al., 2013; Wolfsdorf et al., 2018). 
If the patient arrives from another facility and received IV or oral fluids, the amount of 
that fluid should be factored into the fluid replacement calculations (Wolfsdorf et al., 
2018). If the patient presents in hypovolemic shock, fluid replacement should be 
increased to 20ml/kg of isotonic saline administered as rapidly as possible via large bore 
cannulas with reassessment after each bolus (Wolfsdorf et al., 2018). Once blood glucose 
levels are less than 300 mg/dl or if the blood glucose levels decrease by more than 90 
mg/dL, IV fluids can be changed to 0.45% Normal Saline and glucose is to be added to 
the fluids to prevent hypoglycemia (Bruzzini et al., 2013; Wolfsdorf et al., 2018). 
Maintenance fluids are required as the vascular volume will decrease as plasma glucose 
concentrations normalize (Wolfsdorf et al., 2018). Oral fluids are typically started within 
24 hours of treatment (Wolfsdorf et al., 2018).  
Insulin therapy should be started at a rate of 0.05-0.1 unit/kg/hour via an IV 
infusion at least 1 hour after the start of fluid replacement (Bruzzini et al., 2013; 
Wolfsdorf et al., 2018; Wolfsdorf et al., 2006;). An IV bolus of insulin is contraindicated 
in children as it may increase the risk of cerebral edema, can precipitate shock, and can 
promote hyperkalemia (Wolfsdorf et al., 2018; Wolfsdorf et al., 2006). Once the 
ketoacidosis is resolved and the patient is tolerating oral fluids, subcutaneous insulin is to 
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be started in conjunction with the IV infusion, which is then slowly tapered off 
(American Diabetes Association, 2019; Wolfsdorf et al., 2018). 
Intracellular potassium is lost because increased plasma osmolality draws 
potassium and water out of cells, in addition to the acidosis and glycogenolysis occurring 
due to insulin deficiency; if the patient presents with vomiting, this also causes potassium 
loss, in addition to urinary loss of potassium due to hyperaldosteronism (Brink, 2014; 
Wolfsdorf et al., 2018; Wolfsdorf et al., 2006). Insulin therapy will push the potassium 
back into the cells, decreasing serum potassium levels (Brink, 2014; Wolfsdorf et al., 
2018; Wolfsdorf et al., 2006). If the patient is hypokalemic, potassium replacement 
should occur at a rate of 20mmol/L, at the same time as initial fluids and prior to insulin 
therapy, as the insulin will cause further hypokalemia (Wolfsdorf et al., 2018; Wolfsdorf 
et al., 2006). If the patient is hyperkalemic, potassium treatment is deferred until urine 
output is documented and then replaced at 20-40 mmol/L (Wolfsdorf et al., 2018). 
Assessment of the electrocardiogram may aid in determining if the patient is hypo- or 
hyperkalemic. Prolonged PR-interval, flattened T-wave, ST-depression, prominent U-
waves, and long QT-intervals are signs of hypokalemia, while tall, peaked T-waves and 
shortened QT-intervals are signs of hyperkalemia (Brink, 2014; Wolfsdorf et al., 2018; 
Wolfsdorf et al., 2006). The maximum rate of potassium replacement is 0.5mmol/kg/h 
(Wolfsdorf et al., 2018).  
Acidosis is reversed with the treatment of fluids and insulin; insulin stops 
additional ketoacid production and aids in the ketoacids being metabolized leading to 
bicarbonate generation, and IV fluids improve perfusion and renal function allowing for 
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the excretion of acids (Wolfsdorf et al., 2018; Wolfsdorf et al., 2006;). The treatment by 
administration of bicarbonate is not recommended unless the patient presents with life-
threatening hyperkalemia or acidosis with a venous pH less than 6.9 and signs of 
compromised cardiac contractility (Wolfsdorf et al., 2018; Wolfsdorf et al., 2006). If 
bicarbonate is to be given, the rate is 1-2 mmol/kg over 60 minutes (Wolfsdorf et al., 
2018; Wolfsdorf et al., 2006).  
Serum sodium levels can be unreliable as glucose in the extracellular fluid causes 
osmotic movement of water into the extracellular fluid (ECF) causing dilutional 
hyponatremia (Wolfsdorf et al., 2018). To verify the corrected sodium level, the formula 
is Na + 2([plasma glucose - 100] / 100)mg/dL and as patient improves the gap between 
the corrected sodium and the serum sodium levels should narrow (Bruzzini et al., 2013; 
Wolfsdorf et al., 2018; Wolfsdorf et al., 2006). As plasma glucose concentration 
decreases the serum sodium should increase; a failure of measured serum sodium levels 
to increase or to decrease more can be seen as a sign of impending cerebral edema 
(Wolfsdorf et al., 2018). 
Serum phosphate is lost due to osmotic diuresis and can continue to fall with 
insulin therapy as phosphate is pushed into the cells (Wolfsdorf et al., 2018; Wolfsdorf et 
al., 2006). Hypophosphatemia may also occur if IV therapy is continued without any oral 
intake of food after 24 hours of therapy (Wolfsdorf et al., 2018; Wolfsdorf et al., 2006). 
Clinical signs include metabolic encephalopathy (irritability, paresthesias, confusion, 
seizures, and coma), impaired myocardial contractility and respiratory failure due to a 
weakened diaphragm, dysphagia, ileus, and thrombocytopenia (Wolfsdorf et al., 2018). 
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Treatment via potassium phosphates is recommended with monitoring of calcium levels 
as the administration of phosphate may induce hypocalcemia (Wolfsdorf et al., 2018; 
Wolfsdorf et al., 2006).  
Oral replacement and transition to subcutaneous (SQ) insulin- Oral intake is 
recommended to be started when the patient has clinically improved and only mild 
acidosis and ketosis is present, or when the venous pH is greater than or equal to 7.3 and 
the bicarbonate level greater than or equal to 18 mEq/L (Logee, 2020; Wolfsdorf et al., 
2018; Wolfsdorf et al., 2006). Once ketoacidosis has resolved, and oral intake is 
tolerated, both long-acting and short-acting insulin should be administered 
subcutaneously, with the first dose being just before mealtime (Wolfsdorf et al., 2018; 
Wolfsdorf et al., 2006). Treatment and type of insulin given are patient-specific; the first 
dose of SC insulin will be given concurrently with IV infusion but the time of 
administration varies on the type of insulin. Before stopping the insulin infusion, rapid-
acting insulin will be given 15-30 minutes prior, regular insulin will be given 1-2 hours 
prior, and long-acting insulin will be given the evening before the infusion is stopped the 
next morning (Wolfsdorf et al., 2018). Strict and frequent blood glucose monitoring is 
continued to prevent hypo- or hyperglycemia (Wolfsdorf et al., 2018).  
Adverse Effects 
Symptomatic cerebral edema occurs in 0.5%-1% of pediatric DKA patients 
(Wolfsdorf et al., 2006). However, cerebral injury is the major cause of mortality and 
morbidity with cerebral edema accounting for 60%-90% of all DKA deaths and with 
10%-25% of survivors of cerebral edema having significant residual morbidity 
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(Wolfsdorf et al., 2018). Cerebral edema typically develops within the first 12 hours of 
treatment but can also occur prior to treatment and is rarely seen 24-48 hours after 
treatment has started (Wolfsdorf et al., 2018). Cerebral edema will present with a 
headache or worsening headache after the initiation of treatment, decreased level of 
consciousness (restlessness, irritability, increased drowsiness, confusion, incontinence), 
cranial nerve disturbances, decreasing oxygen saturation, and a late sign of Cushing’s 
triad (increasing blood pressure, bradycardia, and respiratory depression) (Wolfsdorf et 
al., 2018; Wolfsdorf et al., 2006). Patients who are at high risk for cerebral edema include 
those with elevated serum urea nitrogen concentration, severe acidosis, and severe 
hypocapnia; those patients with a higher degree of dehydration and hyperventilation are 
at more risk than those with higher blood glucose levels or osmotic changes during 
treatment (Wolfsdorf et al., 2018; Wolfsdorf et al., 2006;). Demographics of patients with 
increased risk include younger pediatrics, new-onset diabetes, and longer duration of 
symptoms (Logee, 2020; Wolfsdorf et al., 2018).  
Diagnostic criteria for cerebral edema include abnormal motor or verbal responses 
to pain, decorticate or decerebrate posture, cranial nerve palsy, and abnormal neurogenic 
respiratory pattern (grunting, tachypnea, Cheyne-Stokes respirations) (Wolfsdorf et al., 
2018). Major criteria for cerebral edema include altered mentation, confusion, fluctuating 
level of consciousness, sustained heart rate deceleration (decrease of more than 20 beats 
per minute) not caused by improved intravascular volume or sleeping, and age-
inappropriate incontinence (Wolfsdorf et al., 2018). Minor criteria for cerebral edema 
include vomiting, headache, lethargy or not easily awakening, diastolic blood pressure 
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>90 mm Hg, and age <5 years (Wolfsdorf et al., 2018). Cerebral edema can be correctly 
diagnosed with a 92% sensitivity if a patient has one diagnostic criterion, two major 
criteria, or one major and two minor criteria (Wolfsdorf et al., 2018).  
If a pediatric patient is showing signs of cerebral edema, IV therapy should be 
decreased to a rate that maintains blood pressure without causing excessive fluid 
administration that may increase cerebral edema (Wolfsdorf et al., 2018). Treatment 
should be hypertonic intravascular fluid, such as mannitol or hypertonic saline; mannitol, 
at a rate of 0.5-1 g/kg IV over 10-15 minutes and hypertonic saline, at a rate of 2.5-5 
ml/kg over 10-15 minutes (Wolfsdorf et al., 2018; Wolfsdorf et al., 2006). The effects of 
mannitol should be seen within 15 minutes and should last 120 minutes; if there is no 
response to the initial dose of mannitol, a subsequent dose or hypertonic saline can be 
administered 15-30 minutes after the initial dose (Wolfsdorf et al., 2018). The head of the 
bed should be elevated to 30 degrees and head should be kept midline and supplies for 
intubation should be readily available for those patients with impending respiratory 
failure (Wolfsdorf et al., 2018). Treatment should not be delayed obtaining cranial 
imaging; clinical symptoms should be utilized to identify cerebral edema, and imaging 
should occur after treatment is complete to determine if there are lesions such as a 
hemorrhage or thrombosis (Wolfsdorf et al., 2018).  
Prevention of Future Diabetic Ketoacidosis Episodes 
DKA management is not complete until the cause has been identified and treated 
(Brink, 2014; Wolfsdorf et al., 2018). In known diabetics, if the DKA is not brought on 
by a febrile illness or gastroenteritis, the most common cause is psychosocial or failure to 
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appropriately administer insulin; in new-onset diabetes, a delay in diagnosis is the most 
common case (Wolfsdorf et al., 2018). There may be a failure to monitor blood glucose 
levels or a failure to administer adequate insulin (Wolfsdorf et al., 2018; Wolfsdorf et al., 
2006). Psychosocial concerns include insulin omission in an attempt to lose weight in 
conjunction with an eating disorder, a way of escaping a difficult home situation, or 
depression (Wolfsdorf et al., 2018; Wolfsdorf et al., 2006;). A psychiatric social worker 
or clinical psychologist should be consulted to identify any psychosocial contributions to 
the development of DKA (Wolfsdorf et al., 2018; Wolfsdorf et al., 2006). Education 
should be provided on the recognition and treatment of DKA and when to seek medical 
help; if patients and parents are appropriately educated, there is a 10-fold decrease in 
DKA recurrence (Wolfsdorf et al., 2018; Wolfsdorf et al., 2006).  
Diabetic Ketoacidosis or Hyperglycemic Hyperosmolar State 
Hyperglycemic hyperosmolar state (HHS) is diagnosed with a blood glucose more 
than 600 mg/dL, venous pH greater than 7.25, serum bicarbonate greater than 15mmol/L, 
absent to mild ketonemia, serum osmolality greater than 320mOsm/kg, and altered 
consciousness (obtundation/combativeness) or seizures (Wolfsdorf et al., 2018). In HHS, 
treatment includes IV fluid replacement to gradually expand volume, restore renal 
perfusion, and correct serum sodium and osmolality (Wolfsdorf et al., 2018). Insulin 
treatment should only occur once glucose levels are decreasing less than 50 mg/dL an 
hour with fluid replacement only and should be started at a rate of 0.025-0.05 units/kg/hr 
(Wolfsdorf et al., 2018).  
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Evidence Generated for the Doctoral Project 
Participants 
Participants included the ED RNs working within the organization; Nurse 
participants volunteered to independently complete the course with there being no 
selection from the project team leader or team. Nurses were notified about the 
educational program through flyers posted in the departments, emails, and huddle 
announcements at each shift; participation was voluntary. The practice-focused question 
was relevant to emergency nurses as they all have the potential to care for a pediatric 
DKA patient.  
Procedures 
A pre- and posttest was created to collect evidence on knowledge and confidence 
gained from the course material. The pre- and posttest was the same and tested the 
learner’s knowledge using multiple choice questions and answers. These tools were 
vetted through the project team before implementation and drew upon the information 
from the evidence discussed above. A program evaluation rubric was used by the project 
team to score the education program (See Appendix D). A course evaluation (See 
Appendix E)was be given to the learners; this evaluation was organization-specific and a 
requirement from the Department of Education. Originally this course was proposed to be 
an in-person lecture with a PowerPoint didactic, given at different times and dates for 
maximum participation. The mode of delivery was changed to self-directed learning 
because a global pandemic, novel corona virus disease (COVID-19) occurred and 
guidelines included to restrict social gatherings to less than five (5) persons. The 
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organization chose to cancel all in-person courses; therefore, the staff education was 
changed to an independent self-learning module with all forms, tests, and materials in a 
packet that had course instructions written on it. 
Protections 
Participation in this project was strictly voluntary and this was presented as an 
option to the staff. All pre- and post-tests, along with course evaluations, were 
anonymous. Copies of the Consent Form for Anonymous Questionnaires from the DNP 
Staff Education Manual were provided to participants. The education program 
participants were asked to identify their course evaluations and pre- and post-tests with a 
number unique to them so that data could be evaluated from before and after the course 
without the ability to identify the individual. These documents were reviewed by the team 
leader only and were stored in a locked drawer that only the team leader could access 
using a key. This key was kept on the team leaders’ person to ensure no other individuals 
had access to confidential records. The participants were notified of these safeguards and 
that course data would not be shared with other nurses, leadership, or the organization. 
Additionally, the Institutional Review Board (IRB) at Walden University approved the 
project, in addition to the protections, prior to the start of the course and data collection 
(IRB approval number 03-06-20-0979807). Signature on the site approval form from the 
DNP Staff Education Manual were obtained prior to IRB approval.  
Analysis and Synthesis 
Data were recorded and tracked in an Excel spreadsheet that was password 
protected; this spreadsheet was located on the team leaders’ laptop which was also 
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password protected. Data on this spreadsheet were organized per unique number and 
included the pre- and post-test scores, in addition to the course evaluation ratings. Data 
were statistically analyzed using SPSS version 25 to determine the effectiveness of the 
program and to answer the practice-focused question. To assure the integrity of the 
evidence, missing information, such as pre- or post-test scores was omitted. Statistical 
analysis included a paired t test comparing the pre- and post-test results to answer the 
practice focused question.  
Summary 
The practice-focused question for this project is: For RNs working in a county 
ED, does a staff education program on evidence-based treatment for pediatric patients 
who present with DKA improve knowledge and confidence of the pathophysiology and 
treatment of DKA in pediatric patients? The evidence to support this question is biphasic; 
evidence from leaders in the care of pediatric DKA, in addition to organization-specific 
information, will be utilized to create the education but also to create the pre- and post-
test for the staff. The pre- and post-test, in addition to the course evaluation, will be 
evaluated statistically to determine the effectiveness of the project. Section 4 will discuss 
the findings and recommendations of this project. 
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Section 4: Findings and Recommendations 
Introduction 
At the project site, a nonprofit county ED, there has been a need for 
supplementary education for RNs on the treatment and care of pediatric patients with 
DKA. Delays in identification and care and poor patient outcomes and complications 
leading to increased morbidity and mortality can be caused by a lack of understanding of 
the pathophysiology, symptomology, and treatment of pediatric DKA (Brink, 2014). The 
gap in practice is that despite internationally recognized guidelines for treatment, there 
are still disparities in the delivery of care and a lack of integration of evidence-based 
practice (Clark & Dalabih, 2014; Zee-Cheng et al., 2017). The practice-focused question 
for this doctoral project was:  
PFQ: For RNs working in a county ED, does a staff education program on 
evidence-based treatment for pediatric patients who present with DKA improve 
knowledge and confidence of the pathophysiology and treatment of DKA in 
pediatric patients?  
The purpose of this project was to educate ED RNs on pediatric DKA and improve their 
knowledge and confidence regarding this disease process and its’ treatment. 
I completed a literature review of peer-reviewed articles using Medline, CINAHL, 
Cochrane Review, and PubMed databases to identify evidence-based practice 
recommendations for emergency nurses who are treating pediatric patients with DKA. 
The search included the following combination of key words: emergency, emergency 
department, pediatric, diabetic ketoacidosis, clinical practice guideline, and evidence. 
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Primary sources of evidence included clinical practice guidelines from the ISPAD, a 
consensus statement and standards of care from the American Diabetes Association, and 
textbooks created by and endorsed by the Emergency Nurses Association and the Society 
of Critical Care Medicine. These sources were utilized to create the staff education and 
the pre- and posttest; all these items were vetted through the project team prior to 
initiation of the staff education. Analysis of knowledge and confidence gained from the 
course regarding the care of a pediatric patient with DKA was achieved with the 
collection and analysis of the pre- and posttest results. This data were recorded and 
tracked in an Excel spreadsheet and was organized per unique number and included the 
pre- and posttest scores, in addition to the course evaluation ratings. I conducted 
statistical analysis, including a paired t test comparing the pre- and posttest results, 
utilizing SPSS version 25 to determine the effectiveness of the program and to answer the 
practice-focused question. Any data that was missing was omitted to assure the integrity 
of the evidence. 
Findings and Implications 
A total of 50 packets were sent out to the ED RNs and a total of 35 RNs 
participated in the study by returning the packet. One RN did not complete the posttest, 
three RNs did not complete the course evaluation, and 16 did not complete the pre- and 
postcourse confidence levels. Data (see Appendix F) were compared between the 34 RNs 
who did fully complete the pre-and posttests and the 19 RNs who completed the pre- and 
postcourse confidence levels. As shown in Table 1, the mean pretest scores (9.97) were 
lower than the mean posttest scores (13.29). On average, the RNs improved their scores 
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by at least three (3) points, meaning they answered three (3) more questions right on the 
posttest. The p value (.000), shown on Table 2, demonstrated a statistically significant 
improvement in posttest scores. Table 3 shows the mean precourse confidence levels 
(3.11 or somewhat confident) were lower than the mean postcourse confidence levels 
(4.11 or fully confident). On average, the RNs increased their confidence level by 1 point. 
Additionally, as shown on Table 4, the p value (.000) leads to the conclusion that there 
would be an increase in confidence levels for any RN taking this course.  
Table 1 
 





N Std. deviation Std. error mean 
Pretest scores 9.97058823529 34 1.71420613515 .293983926821 
Posttest scores 13.2941776470 34 1.60547192655 .275336163889 
 
Table 2  
 
Pre- and Posttest Scores Paired Differences 
    95% confidence interval 
of the difference 
   




lower Upper t df Sig.  
(2-tailed) 
Pretest score – 
 Post-test 
score 













Pretest confidence 3.11 19 .809 .186 




Table 4  
 
Pre- and Posttest Confidence Paired Differences 
    95% confidence interval 
of the difference 
   










-1.000 .882 .202 -1.425 -.575 -4.943 18 .000 
 
The course evaluation asked participants to review the course on a numeric scale 
from 4-excellent, 3-good, 2-fair, and 1-poor. Table 5 shows the mean results of 3.91 for 
clarity of content, relevance to clinical practice, support materials, and overall evaluation, 
with a mean of 3.81 for my understanding of the content. Additionally, when asked if 
they would recommend this course to a colleague, all answered “yes” (see Appendix G). 
Specific course evaluation comments (Table 6) determined that the course was 
considered easy to understand, detailed, and informative. 
Table 5  
 
Course Evaluation Data 











Mean 3.91 3.81 3.91 3.91 3.91 
N 32 32 32 32 32 
Std. deviation .296 .397 .296 .296 .296 




Table 6  
 




2 Very well presented, easy to follow and understand 
13 Easy to understand 
17 More detailed than I expected; it provided great refresher info, as well as new info that I was not 
aware of 
25 Informative 
221 Excellent course, very clear and to the point 
1010 Very informative! 
1503 Very informative 
8912 Information was clear, concise, and well presented 
51501 Great! Informative! 
74324 Great presentation, info was presented in clear flow, easy to learn and retain 
1000000 Great information. Easily understood. 
 
The major unanticipated limitation in the implementation of this project was that 
during this time the world is facing a pandemic due to an outbreak of novel coronavirus 
(COVID-19). Due to this outbreak the original format for this course, an in-person 
PowerPoint presentation, could not occur. The course was then changed to a handout 
with written material that was returned by the RN. The packet did ask the nurses to work 
independently and to complete the pretest without looking at the material; the pretest was 
also placed before the course content in an effort to prevent the RNs from reviewing the 
material first. However, as the RNs anonymously completed the packets, there is no way 
of determining if this actually occurred; findings from data analysis demonstrated an 
improvement in every respondents scores, which could be correlated to them completing 
the pretest without reviewing the material first. Another limitation is that there is no way 
to determine that the RNs retain the information the course provided and will utilize it the 
next time a potential pediatric DKA patient presents to the ED. Ideally there should be a 
decrease in admission rates and length of stays for these patients; however, the evaluation 
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of patient outcomes is not a part of this project. An unanticipated outcome of this course 
was that out of the questions, the most common posttest questions RNs answered 
incorrectly were regarding diagnostic testing prior to treatment for cerebral edema and 
psychologic causes of DKA. The impact of this finding is that the RNs did not fully 
understand these concepts and in practice this could lead to a delay in treatment of 
cerebral edema and a relapse into DKA if staff do not address the psychological causes of 
DKA. 
These findings discussed above have individual, community, institutional, and 
systems level implications. For the RN as an individual, the findings determine that RNs 
can increase their knowledge base and raise their confidence level in caring for pediatric 
patients with DKA using a self-directed education program. At an individual and a 
community level these findings would correlate to earlier identification of pediatric DKA 
by ED RNs, resulting in improved care and decreased complications. At an institutional 
level, this increased knowledge base has the potential for earlier recognition and 
treatment of pediatric DKA, leading to fewer patients being admitted and a decrease in 
length of stay for those patients admitted. At a system level, these findings determine that 
refresher courses on critical elements such as complex patient events such as DKA lead 
to improved knowledge and confidence in caring for patients, leading to better care and 
decreased complications. This project led to increased ED RN knowledge and confidence 
with pediatric DKA patients, which has the potential to lead to early recognition and 
treatment of pediatric DKA patients presenting to the ED, decreased admission rates, 
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reduced lengths of stay, and improved outcomes. All this may lead to a healthier diabetic 
pediatric population and potentially decrease morbidity and mortality for this population. 
Recommendations 
Recommended solutions that will potentially address the gap-in-practice stated 
above revolve around continued education of the staff. Although the results demonstrated 
that an educational packet aids in closing the gap as evidenced by improved knowledge 
and confidence scores, an interactive in-person lecture using the course material may lead 
to even more improved confidence levels and knowledge retainment. Using the course 
material along with the pre-/posttest and pre-/posttest answer key would be an ideal way 
to continue to improve ED RNs knowledge and confidence in caring for pediatric DKA 
patients. Staff should be given enough time to sign up for the course, and multiple date 
and time offerings will improve course attendance. Administering only the pretest prior 
to the start of the course would be beneficial in obtaining an accurate pretest result. A 
posttest administered immediately after the completion of the course would evaluate 
knowledge gained; however a posttest administered at least 1 week later would evaluate 
knowledge retained. As pediatric patients with DKA in the ED is common but not 
common enough that RNs are able to obtain and maintain a solid knowledge and 
confidence base, frequent reeducation on this topic is necessary to fully decrease the gap-
in-practice. 
Contributions of the Doctoral Project Team 
The doctoral project team consisted of myself, a pediatric emergency medicine 
provider, an ED clinical educator, a PICU physician, and a PICU clinical educator. My 
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responsibilities included everything in this project from research of evidence, 
development of the educational program, and collection and analysis of data. The 
responsibilities taken on by the other team members included reviewing all the course 
content and materials and providing feedback. Based on feedback received (Appendix F) 
some changes were made to the final presentation that was given to the ED RNs. Plans to 
extend this project beyond the DNP doctoral project include teaching the course as it had 
originally been planned, an in-person interactive lecture. An additional plan is to publish 
this DNP project as a quality improvement project in the Journal of Emergency Nursing. 
Strengths and Limitations of the Project 
Strengths of this project include that the project was successful in increasing staff 
knowledge and confidence in the care of pediatric DKA patients in addition to receiving 
positive feedback via the course evaluations. The information was provided concisely and 
clearly, and the RNs found it to be very informative. Additionally, this topic is one that is 
important to ED RNs as these patients often present to the ED, and staff must be 
knowledgeable in the recognition and care of these patients. Limitations of this project 
include that the course was not able to be presented in the format originally intended, and 
due to this, there is no way to ensure that the data is completely accurate or if there would 
be a change in the course evaluations. Recommendations for future projects include 
continued education on pediatric specific clinical presentations of diseases and disorders 
in either an in-person or self-learning teaching modality. Additionally, education on any 
high-risk, low-frequency topic, such as eclampsia or care of patients with 
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ventriculostomies, would also be beneficial for ED RNs who may not feel comfortable 
caring for these patient populations. 
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Section 5: Dissemination Plan 
Dissemination Plan 
Dissemination of this project at the current practice site in addition to other 
practice sites will lead to advancing nursing practice and confidence when caring for 
pediatric patients with DKA, resulting in improved patient outcomes and decreased 
adverse effects and reoccurrences of DKA. Plans to disseminate this work to the 
institution staff include providing an in-person lecture at a later time to allow for diverse 
learning styles and needs. As this project is in regard to pediatric patients with diabetes, 
this course would be appropriate for anyone who cares or will care for these patients 
including nurses working in the ED, inpatient pediatric departments, outpatient pediatric 
clinics, and residents and nursing students. Appropriate dissemination to the broader 
nursing profession includes providing the course at different organizations so more 
nurses can receive the material, in addition to publishing the educational material to a 
journal such as the Journal of Emergency Nursing. 
Analysis of Self 
My career as an RN has always been about progression and challenging myself. I 
started as a new graduate RN training and working in the ED. During this time, I had 
self-doubts that made me think the ED may not be the right setting for me, and perhaps I 
would not succeed. As my experience grew, my confidence also grew, and I tried to 
foster learning in my coworkers and new nurses coming into the ED. After 5 years as a 
bedside RN, I decided to challenge myself by applying for an ED clinical educator 
position at a different organization, which allowed me to grow as a learner and leader, 
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learning the results of effective and ineffective leadership. Leaving this position, I briefly 
worked at an organization that also had some ineffective leadership; however, my 
position in this organization allowed me to find my voice and speak up in a professional 
manner. In my position now at a different organization, I feel that I have stagnated in the 
role of a clinical educator but am excited to try a different challenge in a different 
position. Additionally, as a young leader, I found there are always individuals who 
challenge my knowledge and ideas; however, I do not let this stop me from ensuring my 
voice is heard, and it motivates me to grow into different positions. I feel that 
complacency leads to stagnation, and it is my goal to never be stagnant. 
As a scholar prior to any type of nursing education I was one who was not the 
most motivated, and though I would be distracted in lectures, I did quite well in school. 
Once I started my RN education, I strived to be a nurse who tried her very best instead of 
one who chose to get by. I had the benefit of attending a program that allowed me to 
achieve both my bachelor’s and master’s degree simultaneously, and I was benefited by 
having professors who truly cared about my growth as a scholar and learner. As an 
inexperienced leader, however, I feel the material I was taught was difficult to grasp as I 
was still working at the bedside. This doctoral program was different, as I have years of 
leadership experience and can reflect on my leadership style in addition to apply concepts 
learned. Although I am at the end of this program, I will strive to continue to grow as a 
scholar and keep my learning alive. 
As a clinical educator I have created staff development material before. In this 
aspect, this project was familiar to me. However, the use of an expert review panel and 
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the data collection and analysis was something that was new to me, and I was excited for 
this challenge and growth. Time management has always been a challenge as I am a 
tenured procrastinator; however, with this project I have had only minor delays and 
setbacks. Challenges included the need for me to change the setting of my project due to 
the inability to obtain IRB approval; however, this was obtained at my clinical setting in a 
very timely manner. The biggest and most unexpected challenge for this project was the 
arrival of novel Coronavirus (COVID-19) to California. The social distancing demands 
forced me to change my project from an in-person lecture to a self-learning module. 
Fortunately, the RNs given the self-learning module promoted my project completion by 
returning the data needed in a very timely manner. 
I have gained several insights during my scholarly journey. Firstly, I have learned 
a lot about the topic of my project, pediatric DKA; one of the reasons why I chose this 
topic was that it was something that I also was not comfortable or fully knowledgeable 
about. I have also gained insight into how to write in a scholarly manner and how to 
present scholarly material in a clear and organized way. As self-doubt is present in any 
individual, I have learned that I am capable of anything I set my mind to, and I have 
knowledge and ideas that are valuable to the nursing profession. I look forward to the 
future projects and endeavors this leads to.  
Summary 
ED nurses often are the first clinician a patient sees in addition to being ever 
present during their treatment in the ED. Pediatric patients present a challenge in that 
they are a specialized patient population with different responses to disease processes, 
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clinical presentations, treatment plans, and adverse reactions. Additionally, with complex 
patient situations, especially ones that may not be seen commonly, it is important that ED 
RNs be up to date on their knowledge of these disease processes in a pediatric patient. 
DKA is a complex disease process which, although is seen in the ED, is not a common 
enough that ED RNs feel comfortable in their knowledge of or care for. As many have 
never diagnosed pediatric diabetic patients presenting to the ED in DKA, it is critical that 
ED RNs be knowledgeable in all facets surrounding this disease process and its’ 
treatment, in addition to feeling confident in caring for this patient. Increased knowledge 
and confidence in caring for pediatric DKA patients can lead to early recognition, 
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Appendix A: Course Material 
PEDIATRIC DIABETIC KETOACIDOSIS IN THE ED
SONYA SANDHU MSN, RN, CEN, PHN
DOCTORAL STAFF DEVELOPMENT PROJECT
 
OBJECTIVES
 Upon completion of this course, the learner will:
 Understand the pathophysiology of pediatric diabetic ketoacidosis (DKA)
 Verbalize the initial and delayed signs and symptoms of DKA in the pediatric patient
 Understand treatment of DKA specific to the pediatric population
 Recognize potential complications of pediatric DKA 
 Verbalize the treatment of pediatric DKA





 The material for this course is compiled from the following:
 Clinical Practice Guidelines from the International Society for Pediatric and Adolescent Diabetes (ISPAD)
 Consensus statement and standards of care from the American Diabetes Association (ADA)




 Since 2000 the number of pediatric patients diagnosed with diabetes has continued to rise.4
 For those pediatric patients newly diagnosed with diabetes, 25-30% present to the Emergency Department with 
an initial diagnosis of DKA and begin the initial treatment at that time. 6, 7, 8
 For these patients, there is an increased risk of presenting with DKA if:
 The patient is younger
 Comes from a family with lower incomes,
 From a household with a lack of health insurance. 6, 7, 8
 ISPAD 2018 clinical practice guidelines recommend that healthcare providers who have the potential to care for 













 Confusion/drowsiness/decreased level of consciousness or loss 
of consciousness
 Dehydration
Assessment of Dehydration 9, 10
 Prolonged capillary refill
 Abnormal skin turgor






 Weak/absent peripheral pulses, hypotension, oliguria
 
ASSESSMENT AND MONITORING (CONT.)
 LOC- If the patient cannot protect their airway (loss of gag reflex), the airway should be secured and a 
nasogastric tube placed to prevent aspiration 2, 9, 10
 Cardiac monitoring:  Assess T-waves for signs of hyper- or hypokalemia 9
 Most pediatric patients will present with normal or high blood pressures and urine output until renal blood flow 
decreases to a critical level 9
 An accurate weight in kilograms is vital as all treatment is based on weight-based calculations 10
 At least hourly assessment of: vital signs, blood glucose, intake and output, and neurologic status 9, 10





 Orders to anticipate include:
 Serum glucose, electrolytes, blood urea nitrogen, creatinine, serum osmolality, venous pH and pCO2, a complete blood count, 
urinalysis, and appropriate cultures (if febrile). 9, 10
 DKA is diagnosed when:
 Hyperglycemia (blood glucose >200mg/dl) 7, 9
 Venous pH < 7.3 or serum bicarbonate < 15 mmol/L 7, 9
 Ketonemia or moderate to large ketonuria 7, 9
 Anion gap 20-30 mmol/L or higher if accompanied by lactic acidosis (normal 10-14 mmol/L) 9, 10
 Calculation for anion gap is Na-(Cl + HCO3) 9, 10
 The severity of DKA is defined by the degree of acidosis in the venous pH 10
 Mild- 7.2-7.3, moderate- 7.1-7.2, and severe-pH<7. 10
 
PATHOPHYSIOLOGY OF DKA
 DKA occurs when there is a deficiency in the circulating insulin and counterregulatory 
hormones (catecholamine, glucagon, cortisol, & growth hormone) 5, 9, 10
 This causes the body to go into an accelerated catabolic state with an increase in glucose production by 
the liver and kidneys with an impairment of peripheral glucose utilization, causing hyperglycemia and 
hyperosmolality 9, 10
 This also causes lipolysis and ketogenesis, that causes ketonemia and ketonuria. 9, 10
 This also causes metabolic acidosis. 9, 10
 The hyperglycemia & hyperketonemia cause osmotic diuresis, dehydration, and a loss of electrolytes (this can be 
more severe if the patient is vomiting due to severe ketosis) 9, 10
 This cycle increases as stress hormone is further produced, leading to more insulin resistance, worsening hyperglycemia & 
hyperketonemia, lactic acidosis due to hypoperfusion, and potential sepsis. 9





 Treatment is dependent on the severity of dehydration.9
 The end goals of treatment are:
 Correct the acidosis and reverse ketosis 1, 9
 Correct dehydration 1, 9
 Normalize blood glucose levels1, 9
 Monitor for complications1, 9
 Identify and treat precipitating events1, 9
 Any emergent presentations should follow Pediatric Advanced Life Support (PALS) guidelines 9
 2 IV access points but central line should be avoided due to increased risk of thrombosis 9
 
TREATMENT- FLUID REPLACEMENT
 Fluid replacement must start prior to the start of insulin therapy to expand blood volume and restore peripheral 
circulation. Fluid deficit should be restored over 24-28 hours. 9, 10
 Isotonic fluid at 10ml/kg over 30-60 minutes or faster if poor tissue perfusion (can be repeated) 3, 9
 Hypovolemic Shock: 20ml/kg 3, 9
 Pre-hospital fluids should be included in overall fluid calculations 9
 Once blood glucose <300, or there is a decrease in more than 90 mg/dL/hour, change to 0.45% NS and add 
glucose 3, 9
 Vascular volume decreases as plasma glucose normalizes 3, 9




TREATMENT- 2 BAG METHOD
 Many organizations utilize this method for 
maintenance fluids for pediatric patients.
 Both bags started concurrently and have the 
same electrolytes, but 1 bag also has 10% 
dextrose added.
 Aids in a gradual decrease in blood glucose levels 
via titration of the fluids, and less titration of the 
insulin
Blood Glucose Bag 1 (No 
Dextrose)
Bag 2 (D 10%)
Greater than 300 100% of total IV 
fluid rate
0% of total IV fluid 
rate
250-300 50% of total IV 
fluid rate
50% of total IV 
fluid rate
200-249 25% of total IV 
fluid rate
75% of total IV 
fluid rate
Less than 200 0% of total IV fluid 
rate




 Start at a rate of 0.05-0.1unit/kg/hr at least 1 hour after start of fluids 3, 9, 10
 IV bolus of insulin increases risk of cerebral edema, can precipitate shock, and promote 
hyperkalemia 9, 10
 When starting the IV insulin, flush the tubing with 20 ml of insulin to saturate the binding sites and 
discard
 Once ketoacidosis is resolved, and the patient can tolerate PO fluids, start 
subcutaneous insulin while slowly tapering off intravenous insulin 1, 9







 Acidosis, gluconeogenesis, and increased plasma osmolality pulls potassium and water out of cells. 2, 9, 10
 Urinary loss due to hypoaldosteronism and vomiting2, 9, 10
 Insulin therapy that pushes potassium back into cells 2, 9, 10
 Replace potassium at a rate of 20mmol/L at the same time as fluids before insulin 9, 10
 Patients can also be hyperkalemic, if so treat after urine output is documented and give fluids with 20-40mmol/L 9
 Assess EKG
 Hypokalemia: prolonged PR-interval, flattened T-wave, ST-depression, U-waves, long QT-interval 2, 9, 10
 Hyperkalemic: tall, peaked T-waves and shortened QT-interval 2, 9, 10
 
TREATMENT- ACIDOSIS
 Acidosis will be corrected during treatment (fluids and insulin) 9, 10
 Insulin stops ketoacid production and aids in its metabolism which generates bicarbonate. 9, 10
 IV fluids improve perfusion and renal function allowing for acid excretion. 9, 10
 Bicarbonate is only to be given if there is life-threatening hyperkalemia or acidosis with venous pH <6.9 and signs 
of compromised cardiac contractility. 9, 10





 Dilutional hyponatremia is seen as water shifts into the extracellular fluid due to the elevated glucose levels. 9
 Corrected Sodium formula is Na + 2([plasma glucose-100]/100) mg/dL.  3, 9, 10
 As patient improves the serum sodium and corrected sodium levels should become more similar. 9
 If there is no increase in serum sodium levels or there is a larger gap, this can be a sign of impending cerebral edema. 9
 
TREATMENT- PHOSPHATE
 Loss due to osmotic diuresis and insulin therapy that pushes phosphate into cells. 9, 10
 Also occurs with IV therapy without oral intake of food within 24 hours of therapy . 9, 10
 Signs of hypophosphatemia
 Metabolic encephalopathy (irritability, paresthesias, confusion, seizures, coma), impaired myocardial contractility and 
respiratory failure d/t a weakened diaphragm, dysphagia, ileus, or thrombocytopenia. 9





 Oral intake should be started when mild acidosis and ketosis is present, or when venous pH is >7.3 and 
bicarbonate is >18mEq/L. 7, 9, 10
 If oral intake is tolerated, long and short acting insulin should be administered with the first dose just before 
mealtime. 9, 10
 Patient specific on which type of insulin (short or long) depending on what patient takes in the past. 9, 10
 If giving rapid-acting insulin, Insulin infusion should be stopped 15-30 min after SQ administration, 1-2 hours after SQ 
administration of regular insulin, and in the am after a long-acting insulin was administered SQ the evening prior.  9, 10
 Patient requires strict and frequent blood glucose monitoring for hypo- or hyperglycemia . 9
 
ADVERSE EFFECTS- CEREBRAL EDEMA
 Symptomatic cerebral edema occurs in 0.5-1% of pediatric DKA patients. 9
 In that percentage, 60-90% patients die and 10-25% of the survivors have significant residual morbidity. 9
 Typically occurs within the first 12 hours of treatment but can also occur prior to treatment and rarely 24-48 hours 
after treatment. 9,
 High risk: those with elevated serum urea nitrogen concentrations, severe acidosis, severe hypocapnia. 9, 10
 Patients with higher degrees of dehydration and hyperventilation at more risk than those with higher blood glucose levels. 9, 10
 Demographics:  younger pediatrics, new-onset diabetes, and longer duration of symptoms. 7, 9
 Symptoms: 
 Headache or worsening headache after the initiation of treatment, cranial nerve disturbances, decreasing oxygen saturation. 9, 10
 Decreased level of consciousness (restlessness, irritability, increased drowsiness, confusion, incontinence). 9, 10




CEREBRAL EDEMA- DIAGNOSTIC CRITERIA
 Diagnostic criteria (needs 1) for cerebral edema include:
 Abnormal motor or verbal responses to pain, decorticate or decerebrate posture, cranial nerve palsy, and abnormal 
neurogenic respiratory pattern (grunting, tachypnea, Cheyne-Stokes respirations). 9
 Major criteria (need 2 or 1 major & 2 minor):
 Altered mentation, confusion, fluctuating level of consciousness, sustained heart rate deceleration (decrease of more than 
20 beats per minute) not caused by improved intravascular volume or sleeping, and age-inappropriate incontinence. 9
 Minor criteria (2 minor with 1 major): 
 Vomiting, headache, lethargy or not easily awakening, diastolic blood pressure >90 mm Hg, and age <5 years. 9
 Cerebral edema can be correctly diagnosed with a 92% sensitivity if a patient has:
 One diagnostic criterion. 9
 Two major criteria. 9
 One major and two minor criteria. 9
 
CEREBRAL EDEMA- TREATMENT
 Decrease IV therapy to a rate that maintains BP without causing excessive fluid administration. 9
 Hypertonic fluid (mannitol or hypertonic saline). 9, 10
 Mannitol- 0.5-1g/kg IV over 10-15 minutes. Works in 15 min and lasts 120 min.9, 10 May repeat or give hypertonic saline 15-
30 min subsequently. 9
 Hypertonic Saline- 2.5-5ml/kg over 10-15 min. 9, 10
 Elevate head of bed to 30 degrees and keep head midline. 9, 10
 May need to be intubated. 9, 10
 Do not delay treatment for cranial imaging, clinical symptoms should be utilized for diagnostics. 9, 10




PREVENTION OF FUTURE EPISODES
 DKA management is not complete until the cause has been identified and treated. 2, 9
 In known diabetics if not due to febrile illness or gastroenteritis the most common cause is psychological or failure to 
appropriately administer insulin. 9
 In new onset diabetics the most common cause is a delay in diagnosis. 9
 Causes:
 Failure to monitor blood glucose levels or failure to administer adequate insulin. 9, 10
 Psychological concerns: insulin omission to lose weight in conjunction with an eating disorder, a way of escaping difficult 
home situation, depression. 9, 10
 Psychiatric Social Worker/Clinical psychologist should be consulted. 9, 10
 Education of patient and family on recognition and treatment of DKA and when to seek help. 9, 10
 Appropriate education decreases DKA recurrence 10-fold. 9, 10
 
DKA OR HYPERGLYCEMIC HYPEROSMOLAR STATE (HHS)
 HHS presents with: 9
 Blood glucose > 600 mg/dL
 Venous pH >7.25
 Serum bicarbonate >15 mmol/L
 Absent to mild ketonemia
 Serum osmolality >320 mOsm/kg
 Altered consciousness (obtundation/combativeness) or 
seizures
 Treatment: 9
 IV fluids to expand volume, restore renal perfusion, and 
correct serum sodium/osmolality
 Insulin once glucose levels are decreasing <50mg/dL an 
hour with fluid replacement only
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Appendix B: Pre-/Posttest 
Unique ID Number________________ 
Pre-Test or Post-Test 
 
Pediatric Diabetic Ketoacidosis Pre/Post Test 
Please circle if this is your PRE or POST test.  Please identify tests with a number unique 
to you. 
Do NOT write your name on this document. 
 
My current confidence level with assessment, knowledge, and treatment of pediatric 
diabetic ketoacidosis is (circle one): 
 
Not Confident at 
All 
Slightly Confident Somewhat 
Confident 
Fairly Confident Extremely 
Confident 
1 2 3 4 5 
 
1. Clinical signs of diabetic ketoacidosis include 
a. Polydipsia, polyuria, 
nausea/vomiting 
b. Confusion, abdominal pain 
c. Dizziness, headache 
d. All of the above 
e. A & B only 
 
2. True/False: Most pediatric patients will present with normal or high blood pressures and 
urine output until critical decreases in renal blood flow. 
a. True b. False 
 
3. DKA is diagnosed with: 
a. Blood sugar greater than 200 mg/dl 
b. Venous pH less than 7.3 or serum bicarbonate less than 15 mmol/L 
c.  Ketonemia or moderate/large ketonuria 
d. Anion gap 20-30 mmol/L 
e. All of the above 
 
4. True/False: Pre-hospital IV fluids should not be included in fluid calculations 
a. True b. False 
 
5. True/False: Fluid replacement must start prior to the start of insulin therapy 
a. True b. False 
 
6. Treatment goals for fluid replacement are to restore fluid deficit over 
a. 4-8 hours 
b. 8-16 hours 
c. 24-28 hours 
d. 24-48 hours 
 
7. Insulin therapy for pediatric DKA is dosed as follows: 
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a. IV bolus of 10 units, and then infusion at 0.05-0.1 units/kg/hr 
b. Subcutaneous bolus of 10 units, and then infusion at 0.05-0.1 units/kg/hr 
c. No bolus, IV infusion of 0.05-0.1 units/kg/hr 
d. No bolus, IV infusion of 0.5-1 units/kg/hr 
8. True/False: Hypokalemia should be corrected with initial fluid administration prior to 
insulin. 
a. True b. False 
 
9. True/False: Sodium Bicarbonate should be given to any pediatric DKA patient who is 
acidotic. 
a. True b. False 
 
10. Those at higher risk for cerebral edema include 
a. During the first 12 hours of treatment 
b. Patients with more severe dehydration and hyperventilation 
c. Younger pediatrics, new -onset diabetes 
d. Higher blood glucose levels 
e. All except D 
 
11. A diagnostic criterion for cerebral edema is 
a. Tachycardia 
b. Abnormal neurogenic respiratory pattern 
c. Vomiting 
d. None of the above 
 
12. Major criteria for cerebral edema include 
a. Fluctuating level of consciousness 
b. Sustained heart rate deceleration 
c. All of the above 
d. None of the above 
 
13. True/False A CT must be obtained prior to initiating treatment for cerebral edema 
a. True b. False 
 
14. In known diabetics causes of pediatric DKA include 
a. Febrile illness 
b. Gastroenteritis 
c. Psychological 
d. Failure to appropriately 
administer insulin 
e. A, B, & D 
f. All of the above 
15. Psychological concerns include 
 
a. Insulin omission to lose weight b. Depression 
c. Escaping a difficult home situation d. All of the above 
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Appendix C: Pre-/Posttest Answer Key 






















































1 9 13 Missing 4 
1 10 12 3 4 
2 11 12 3 4 
2 9 14 3 Missing 
3 10 15 2 3 
4 9 11 Missing 4 
5 11 12 3 4 
9 10 14 4 4 
13 9 14 3 4 
14 10 13 Missing Missing 
17 10 14 4 5 
17 5 15 3 Missing 
24 9 11 3 5 
25 13 15 4 4 
38 9 14 4 Missing 
67 11 15 3 4 
72 7 10 Missing Missing 
100 11 14 Missing Missing 
221 11 14 2 5 
1010 10 11 1 Missing 
1020 10 10 4 Missing 
1207 9 Missing 3 Missing 
1216 10 12 Missing Missing 
1503 10 15 2 Missing 
2020 7 11 2 Missing 
2023 14 15 3 4 
2417 10 13 3 4 
8124 11 12 Missing 4 
8912 7 15 3 3 
51501 10 14 3 4 
69420 11 15 4 4 
74324 11 15 1 4 
101708 11 15 4 4 
359359 11 14 1 Missing 























1 4 4 4 4 4 Yes   
1 4 4 4 4 4 Yes   
2 4 4 4 4 4 Yes   
2 4 4 4 4 4 Yes 
Very well presented, 
easy to follow and 
understand 
3 4 4 4 4 4 Yes   
4 4 4 4 4 4 Yes   
9 4 4 4 4 4 Yes   
13 4 3 4 4 4 Yes Easy to understand 
14 4 4 4 4 4 Yes   
17 4 4 4 4 4 Yes 
More detailed than I 
expected; it provided 
great refresher info, 
as well as new info 
that I was not aware 
of 
17 3 3 3 3 3 Yes   
24 4 4 4 4 4 Yes   
25 4 4 4 4 4 Yes Informative 
38 3 3 3 3 3 Yes   
67 4 4 4 4 4 Yes   
72 4 4 4 4 4 Yes   
100 3 3 3 3 3 Yes   
221 4 4 4 4 4 Yes 
Excellent course, 
very clear and to the 
point 
1010 4 4 4 4 4 Yes Very informative! 
1020 4 4 4 4 4 Yes   
1503 4 4 4 4 4 Yes Very informative 
2020 4 4 4 4 4 Yes   
2023 4 4 4 4 4 Yes   
2417 4 4 4 4 4 Yes   
8124 4 4 4 4 4 Yes   
8912 4 4 4 4 4 Yes 
Information was 
clear, concise, and 
well presented 
51501 4 4 4 4 4 Yes Great! Informative! 
69420 4 3 4 4 4 Yes   
74324 4 4 4 4 4 Yes 
Great presentation, 
info was presented in 
clear flow, easy to 
learn and retain 
101708 4 4 4 4 4 Yes   
359359 4 3 4 4 4 Yes   
1000000 4 4 4 4 4 Yes 
Great information. 
Easily understood 
 
 
